Color vision in epileptic adolescents treated with valproate and carbamazepine

Seizure

Volumn 13, Issue 6, 2004, Pages 411-417

  Verrotti, A ^a   Lobefalo, L ^b   Priolo, T ^a   Rapinese, M ^b   Trotta, D ^a   Morgese, G ^c   Gallenga, P E ^b   Chiarelli, F ^a  

^a Policlinico   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Carbamazepine; Color vision; Epilepsy; Short wavelength automated perimetry; SWAP; Valproic acid

Indexed keywords

CARBAMAZEPINE; VALPROIC ACID;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CLINICAL ARTICLE; COLOR VISION DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; MONOTHERAPY; OUTCOMES RESEARCH; PERIMETRY; PRIORITY JOURNAL; RETINOGRAPHY; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY ANALYSIS; SLIT LAMP; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISION TEST; VISUAL ACUITY; VISUAL FIELD;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; COLOR PERCEPTION; EPILEPSY; FEMALE; HUMANS; MALE; VALPROIC ACID; VISUAL PERCEPTION;

EID: 3543110827     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2003.09.006     Document Type: Article

References (25)

1. Mecarelli O. Rinalduzzi S. Accornero N. Changes in color vision after a single dose of vigabatrin or carbamazepine in healthy volunteers Clin. Neuropharmacol. 24 2001 23-26
2. Bayer A.U. Thiel H.J. Zrenner E. Dichgans J. Kuehn M. Paulus W. et al. Color vision tests for early detection of antiepileptic drug toxicity Neurology 48 1997 1394-1397
3. Nousiainen I. Kalvainen R. Mantyjarvi M. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy Ophathalmology 107 2000 884-888
4. Lopez L. Thomson A. Rabinowicz A.L. Assessment of colour vision in epileptic patients exposed to single-drug therapy Eur. Neurol. 41 1999 201-205
5. Steinhoff B.J. Freudenthaler N. Paulus W. The influence of established and new antiepilectic drugs on visual perception. I. A placebo-controlled, double-blind, single-dose study in healthy volunteers Epilepsy Res. 29 1997 35-47
6. Steinhoff B.J. Freudenthaler N. Paulus W. The influence of established and new antiepilectic drugs on visual perception. II. A controlled study in patients with epilepsy under long-term antiepilectic medication Epilepsy Res. 29 1997 49-58
7. Nousiainen I. Kalvainen R. Mantyjarvi M. Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers Br. J. Ophthalmol. 84 2000 622-625
8. Tomson T. Nilsson B.Y. Levi R. Impaired visual contrast sensitivity in epileptic patients treated with carbamazepine Arch. Neurol. 45 1988 897-900
9. Bayer A. Retinale funktionsstorungen bej patienten unter antikonvulsiver therapje. Medical Thesis, University of Tubingen, 1991.
10. Stamper R.L. The effect of glaucoma on central visual function Trans. Am. Ophthalmol. Soc. 82 1984 792-826
11. Accornero N. Gregori B. Galiè E. De Feo A. Agnesi R. A new color VEP procedure discloses asymptomatic visual impairments in optic neuritis and glaucoma suspects Acta Neurol. Scand. 102 2000 258-263
12. Verrotti A. Lobefalo L. Chiarelli F. Mastropasqua L. Ciancaglini M. Morgese G. Color vision and persistent microalbuminuria in children with type-1 (insulin-dependent) diabetes mellitus: a longitudinal study Diabetes Res. Clin. Pract. 30 1995 125-130
13. Paulus W. Schwarz G. Steinhoff B.J. The effect of anti-epilectic drugs on visual perception in patients with epilepsy Brain 119 1996 539-549
14. Mastropasqua L. Verrotti A. Lobefalo L. Chiarelli F. Verdesea G. Morgese G. Visual field defects in diabetic children without retinopathy: relation between visual function and microalbuminuria Acta Ophthalmol. Scand. 73 1995 125-128
15. Lobefalo L. Verrotti A. Mastropasqua L. Della Loggia G. Cherubini V. Morgese G. et al. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy Diabetes Care 21 1998 2003-2006
16. Sample P.A. Weinreb R.N. Color perimetry for assessment of primary open-angle glaucoma Invest. Ophthalmol. Vis. Sci. 31 1990 1869-1875
17. Pokorny J. Smith V.C. Verriest G. Pinckers A.J.L.G. Congenital and acquired color vision defects. New York: Grune Stratton; 1979
18. Accornero N. Capozza M. De Feo A. Rinalduzzi S. De Marinis M. Pecori-Giraldi J. et al. Video color perimetry: impairment in glaucoma suspects Doc. Ophthalmol. 103 2001 81-90
19. Harwerth R.S. Smith E.L. III Chandler M. Progressive visual field defects from experimental glaucoma: measurements with white and colored stimuli Optom. Vis. Sci. 76 8 1999 558-570
20. Daneshvar H. Racette L. Coupland S.G. Kertes P.J. Guberman A. Zackon D. Symptomatic and asymptomatic visual loss in patients taking vigabatrin Ophthalmology 106 1999 1792-1798
21. Hilton E.J. Cubbidge R.P. Hosking S.L. Betts T. Comaish I.F. Patients treated with vigabatrin exhibit central visual function loss Epilepsia 43 2002 1351-1359
22. MacDonald R.L. Kelly K.M. Mechanisms of action of currently prescribed and newly developed antiepilectic drugs [review] Epilepsia 35 Suppl. 4 1994 S41-S50
23. Ahnelt P.K. Kolb H. Short-wavelength-sensitive cones: morphology and color-specific connections. In: Drum B, editor. Colour vision deficiencies XII. Dordrecht: Kluwer; 1995. p. 285-97
24. Brindley G.S. The summation areas of human colour receptive mechanisms at increment threshold J. Physiol. (Lond.) 124 1954 400
25. Green D.G. The contrast sensitivity of the colour mechanisms of the human eye J. Physiol. (Lond.) 196 1968 415